Hypothesis

Aging-related endothelial p53 senescence increases von Willebrand factor (vWF) and Factor VIII (FVIII) secretion, but this effect is markedly amplified in brain, lung, and liver microvasculature when intermittent hypoxia activates HIF-1α, which cooperates with p53 to drive transcription of the vWF gene. ABO non-O alleles further potentiate the shift by reducing clearance of vWF-FVIII complexes, creating a feed-forward loop that raises thrombin generation specifically in those organs.

Mechanistic Reasoning

1. p53-dependent senescence upregulates vWF via a p53-responsive element in the vWF promoter (shown in vitro).
2. Intermittent hypoxia stabilizes HIF-1α, which binds hypoxia-response elements (HREs) near the vWF promoter and recruits p300/CBP, enhancing transcriptional output.
3. In organs with higher baseline oxygen fluctuations (brain, lung, liver), endothelial cells experience repeated hypoxic spikes, leading to HIF-1α pulses that synergize with chronic p53 activation.
4. ABO non-O glycosylation reduces the affinity of von Willebrand factor for hepatic lectin receptors, slowing clearance and prolonging plasma half-life.
5. The combined increase in vWF prolongs FVIII survival, elevating endogenous thrombin potential (ETP) and peak thrombin, thereby linking organ-specific coagulopathy to local microthrombi and systemic cardiovascular risk.

Testable Predictions

• Prediction 1: In endothelial cells from brain, lung, and liver of aged donors, simultaneous p53 activation and HIF-1α stabilization will produce vWF mRNA levels >2-fold higher than in

Hypothesis

Crocetin does not merely rescue mitochondrial function; it actively reshapes the senescence phenotype of astrocytes, converting them from a pro‑inflammatory SASP state to a regulated, growth‑arrested state that secretes factors modulating neuronal HIF-1α stability. This astrocytic‑neuronal crosstalk creates a bistable switch in HIF-1α activity that sustains neuroprotection without triggering oxidative stress.

Rationale

• Crocetin crosses the BBB by passive transcellular diffusion and reaches brain concentrations within 60‑90 min after oral dosing (https://onlinelibrary.wiley.com/doi/10.1155/2020/1575730). It preserves barrier integrity by stabilizing tight junctions and lowering MMP-9 (https://www.tandfonline.com/doi/full/10.1080/17590914.2025.2603409).
• In aged mice, crocetin upregulates electron transport chain genes, restores OXPHOS, and elevates ATP and NAD+ without raising ROS (https://pubmed.ncbi.nlm.nih.gov/39416964/). Similar NAD+ rescue occurs in primary astrocytes (https://d197for5662m48.cloudfront.net/documents/publicationstatus/155375/preprint_pdf/e1d4b0c8ba962323c595c76e1ac53f2b.pdf).
• Declining NAD+ mimics hypoxia and can stabilize HIF-1α; conversely, NAD+ boost promotes HIF-1α degradation via PHD activation. Thus crocetin-induced NAD+ rise could tip HIF-1α toward a low-activity state in neurons unless counterbalanced by astrocytic signals.
• Senescent astrocytes secrete a SASP that includes cytokines capable of inhibiting neuronal proliferation and influencing HIF-1α through autocrine loops. The seed idea frames senescent cells as "hostage

Hypothesis

Aging alters gut microbiota composition, increasing production of phenylacetic acid (PAA) which chronically activates enterochromaffin (EC) cells via aryl hydrocarbon receptor pathways, driving mitochondrial ROS accumulation, senescence‑associated secretory phenotype (SASP) and a progressive loss of tryptophan hydroxylase 1 (TPH1) activity. Concurrently, age‑dependent downregulation of FFAR2 receptors reduces responsiveness to beneficial SCFAs, further diminishing 5‑HT release. Together, these mechanisms impair local 5‑HT signaling and contribute to age‑related gastrointestinal motility disorders.

Mechanistic Basis

• Microbiota shift: Longitudinal studies show enrichment of PAA‑producing Clostridia species in older humans, raising luminal PAA levels (cite: [https://pmc.ncbi.nlm.nih.gov/articles/PMC9630942/]).
• PAA‑induced senescence: PAA triggers endothelial cell senescence through mitochondrial H₂O₂ and p16^INK4a^ upregulation (cite: [https://doi.org/10.1101/2023.11.17.567594]). EC cells express similar oxidative stress sensors and aryl hydrocarbon receptors, making them susceptible to the same pathway.
• EC‑specific impact: Senescent EC cells exhibit SASP factors (IL‑6, TGF‑β) that inhibit TPH1 transcription via SMAD‑dependent repression, directly cutting 5‑HT synthesis.
• FFAR2 desensitization: Aging reduces FFAR2 mRNA in EC cells (cite: [https://pmc.ncbi.nlm.nih.gov/articles/PMC12547937/]), weakening butyrate‑mediated cAMP signaling that normally potentiates vesicle exocytosis.
• Local 5‑HT deficit: Because gut‑derived 5‑HT acts

Hypothesis

Constitutive expression of X‑escapee demethylases KDM6A and KDM5C in XX cells maintains tumor‑suppressor promoters (CDKN2A, PTEN, TP53) in a stable bivalent configuration, postponing malignant transformation while simultaneously sustaining microglial pro‑inflammatory programs in the aged brain.

Mechanistic Rationale

• KDM6A removes repressive H3K27me3, KDM5C removes activating H3K4me3. When both are present at elevated dosage due to escape from X‑inactivation, they generate a dynamic equilibrium that preserves both marks on nucleosomes flanking key regulatory regions.
• At tumor‑suppressor loci, this equilibrium prevents full transcriptional activation (which could trigger premature senescence or apoptosis) and also blocks complete silencing, keeping the genes in a poised state that resists oncogenic reprogramming.
• In microglia, the same activity skews the balance toward H3K27me3 loss at IRF5 and other inflammatory promoters, as shown in stroke models where higher KDM6A/KDM5C exacerbates ischemic injury[[https://pmc.ncbi.nlm.nih.gov/articles/PMC12222549/]].
• The net effect is a trade‑off: reduced cancer incidence in mitotic tissues but increased late‑on‑set neuroinflammation, matching the male‑female health‑survival paradox.

Testable Predictions

1. Bivalency enrichment – Young adult XX mice will show higher co‑occupancy of H3K4me3 and H3K27me3 at CDKN2A, PTEN, and TP53 promoters in liver, lung, and mammary epithelium compared with XY gonadal‑sex‑matched controls.
2. Age‑dependent erosion – With advancing age, XX tissues will exhibit a progres

NAD+‑SIRT6 chromatin brake hypothesis

Aging cells lose NAD+ not just as a fuel shortage but as a signal that engages a nuclear deacetylase, SIRT6, to remodel chromatin at metabolic‑gene promoters. Low NAD+ reduces SIRT6 activity, which in turn allows aberrant acetylation of histone H3K9 at promoters of genes governing mitochondrial biogenesis and autophagy. This aberrant acetylation recruits a repressive complex containing HDAC3 and the corepressor NCoR, shutting down transcription. The resulting drop in mitochondrial output further limits acetyl‑CoA synthesis, creating a vicious cycle that locks the cell into a low‑energy, low‑repair state. The cycle is testable: restoring NAD+ should reactivate SIRT6, normalize H3K9 acetylation, and revive mitochondrial gene expression only if the SIRT6‑HDAC3 axis is intact.

Key predictions

• In aged mouse liver, nuclear NAD+ levels will correlate inversely with H3K9ac at the promoters of Ppargc1a (PGC‑1α) and Map1lc3b (LC3B) NAD+ decline driven by CD38.
• Genetic ablation of SIRT6 in young mice will mimic the aged chromatin signature and reduce oxygen consumption rate (OCR) by ~30 % without altering total NAD+ pools SIRT1‑AMPK axis.
• Overexpressing a catalytically dead SIRT6 mutant will block the benefits of NAD+ precursor supplementation on histone acetylation and OCR, confirming that SIRT6 activity—not merely NAD+ abundance—is required for the rescue ACSS2 phosphorylation.
• P

Hypothesis

Rapamycin extends lifespan by amplifying a nutrient‑scarcity signal that boosts serotonin release from enterochromaffin (EC) cells, thereby shifting physiological priority from growth and reproduction to somatic maintenance. This effect does not reverse age‑related EC‑cell loss or mitochondrial damage; instead it phenocopies the adaptive response to famine that evolved to survive periods of low energy intake.

Mechanistic Rationale

• mTORC2 inhibition in placental trophoblasts increases serotonin secretion by 49% without altering TPH1 activity [PMC8807024]; chronic rapamycin elevates brain serotonin and produces antidepressant‑like effects across ages [PMC3454865][PubMed 18534253].
• Chronic stress suppresses mTORC1 signaling and reduces hippocampal synapses, mirroring the serotonergic outcome of rapamycin [Frontiers Pharmacol 2021].
• Gut EC cells generate >90% of bodily serotonin and upregulate TPH1 2‑3‑fold in response to microbiome‑derived short‑chain fatty acids (SCFAs), a pathway activated during caloric restriction [PMC5839326][PMC4396604].
• No evidence shows that rapamycin restores aged EC‑cell numbers or repairs mitochondrial dysfunction; the serotonergic rise is a downstream read‑out of pathway inhibiti

Hypothesis

Circadian fluctuations in intracellular α‑ketoglutarate (α‑KG) drive rhythmic activity of KDM6 histone demethylases at core clock gene promoters, maintaining a permissive H3K27me3 landscape that sustains robust clock transcription. With age, declining SLC1A5‑mediated glutamine import reduces α‑KG, blunting KDM6 oscillations, leading to progressive H3K27me3 accumulation, dampened clock gene expression, loss of temporal coherence, and accelerated aging phenotypes. Restoring α‑KG rhythms—via timed glutamine supplementation, SLC1A5 overexpression, or cell‑permeable α‑KG esters—should rescue circadian epigenetics and extend healthspan.

Mechanistic Rationale

1. α‑KG as a circadian metabolite – Glutamine uptake via SLC1A5 exhibits diurnal variation, providing substrate for glutamate dehydrogenase and producing α‑KG in phase with the clock SLC1A5-dependent glutamine flux. α‑KG is a required co‑factor for the Fe(II)/2‑oxoglutarate‑dependent KDM6 (JmjC) demethylases that remove H3K27me3.
2. Rhythmic KDM6 activity – Oscillating α‑KG levels would produce cyclic KDM6 catalytic activity, resulting in timed removal of repressive H3K27me3 marks at promoters of Bmal1, Clock, Per, and Cry genes. This creates a permissive chromatin state that coincides with the transcriptional activation phase of the circadian loop.
3. Age‑related decoupling – Aging diminishes SLC1A5 expression and glutamine flux, lowering α‑KG pools SLC1A5-dependent glutamine flux. Consequently, K

Background

HSV-1 infects ~67% of the global population under 50; HSV-2 affects ~11%. Both establish lifelong latency with no cure. Despite decades of attempts, no approved HSV vaccine exists. The most advanced candidate — GSK's Herpevac (gD/AS04) — failed in a Phase 3 trial of 8,000+ women. Understanding why is the key to what comes next.

Why Herpevac Failed

The failure was not a lack of antibodies — it was the wrong kind. Herpevac induced neutralising IgG1 antibodies exclusively, but women with natural chronic HSV-2 infection were protected by a fundamentally different immune mechanism: antibody-dependent cell-mediated cytotoxicity (ADCC). Vaccinated women showed significantly lower ADCC compared to naturally infected women (P < .001). Single-antigen gD vaccines cannot replicate the polyfunctional antibody breadth of natural infection.

Compounding this: HSV actively evades immune killing via gE and gI glycoproteins, which function as viral Fc receptors that bind and inactivate host antibodies, blocking ADCC. Including gD in vaccines may paradoxically facilitate immune escape. Additionally, subunit vaccines fail to generate CD8+ tissue-resident memory T-cells (TRM) in the genital mucosa — the exact anatomical site where HSV establishes infection.

Hypothesis

A multivalent mRNA vaccine encoding gC, gD, gB, and gE-deleted constructs — deliberately excluding intact gE/gI — administered intramuscularly with a mucosal boost in HSV-1 seropositive adults will elicit superior ADCC responses and genital tract CD8+ TRM cells compared to single-antigen gD vaccination, re

Hypothesis

Selective autophagy does not follow a universal cargo hierarchy; instead, parallel receptor pathways (p62/SQSTM1, NBR1, OPTN, SEC62) compete for ubiquitin chains within phase‑separated condensates, and the outcome of this competition dictates which substrate—ER, mitochondria, or ECM‑associated proteins—is degraded first. With advancing age, alterations in receptor phosphorylation and ubiquitin chain topology shift the balance toward preferential ER‑phagy, suppressing mitophagy and ECM‑protective autophagy, leading to accumulated mitochondrial damage and maladaptive matrix remodeling.

Mechanistic Reasoning

• p62 and NBR1 form cooperative condensates that bind ubiquitinated cargo; NBR1 acts as a chain terminator, promoting condensate growth, while p62 provides scaffolding for ULK1 recruitment (https://pmc.ncbi.nlm.nih.gov/articles/PMC12669772/, https://pmc.ncbi.nlm.nih.gov/articles/PMC12740005/).
• In inflammatory muscle atrophy, OPTN and SEC62 are up‑regulated early, indicating ER‑phagy precedes mitochondrial turnover (https://doi.org/10.1101/2025.05.06.650963).
• Parkin‑dependent mitophagy accounts for only ~25% of mitochondrial protein turnover; BNIP3/NIX‑mediated pathways dominate under hypoxia (https://doi.org/10.1080/15548627.2019.1586258).
• FGF21‑driven autophagy improves ECM homeostasis via SIRT1‑mTOR signaling, not direct collagen degradation ([https

Hypothesis

Transient induction of the germline RNA‑binding protein DAZL in postnatal c‑Kit⁺ cardiac progenitor cells (CPCs) will simultaneously reinforce telomere maintenance and trigger apoptosis of cells bearing short telomeres or DNA damage, thereby recreating the germline’s multi‑layered rejuvenation strategy in the somatic heart.

Mechanistic Rationale

• DAZL recruits telomerase to chromatin: In germ cells, DAZL interacts with TERT and TCAB1 to promote telomere elongation [https://pmc.ncbi.nlm.nih.gov/articles/PMC7072777/]. Ectopic DAZL in CPCs is expected to increase TERT binding at telomeres, counteracting the postnatal decline of telomerase activity that leaves telomeres vulnerable to attrition.
• DAZL sensitizes damaged cells to p53‑dependent apoptosis: DAZL binds and stabilizes p53 mRNA, enhancing p53 translation upon genotoxic stress [https://escholarship.org/content/qt0p27v7pf/qt0p27v7pf_noSplash_629ada1a4b217a2859c97cc8a82d5997.pdf]. In CPCs with critically short telomeres or mitochondrial ROS‑induced telomere damage [https://doi.org/10.15252/embj.2018100492], heightened p53 would shift the balance from senescence‑associated autophagy toward apoptosis, mimicking the germline’s ruthless culling of defective cells.
• Coupling creates a feedback loop: Telomere elongation reduces the pool of damage‑induced p53 activation, while apoptosis of the most damaged CPCs lowers SASP production, alleviating paracrine senescence [https://pmc.ncbi.nlm.nih.gov/articles/PMC6516154/]. This dual action should preserve a younger, more proliferative CPC compartme

Hypothesis

The magnitude of the pupillary light reflex (PLR) elicited by a brief, standardized 480 nm light pulse upon waking predicts the size of the circadian phase advance produced by a subsequent morning light exposure session.

Mechanistic Basis

Intrinsically photosensitive retinal ganglion cells (ipRGCs) expressing melanopsin drive two parallel pathways: (1) projection to the suprachiasmatic nucleus (SCN) that mediates melatonin suppression and phase shifting, and (2) projection to the olivary pretectal nucleus that governs the PLR. Individual differences in ipRGC melanopsin content or coupling efficiency therefore covary with both PLR amplitude and circadian light sensitivity. This predicts a positive correlation between PLR response strength and the degree of phase advance achieved after a fixed dose of morning light.

Testable Predictions

1. Participants with larger PLR constriction amplitudes (≥ 0.3 mm) to a 100 ms 480 nm pulse will show ≥ 15 min greater salivary DLMO advance after 30 min of 10 000 lux blue‑enriched light than those with smaller amplitudes (≤ 0.15 mm).
2. The PLR‑phase advance relationship will hold across chronotypes after adjusting for baseline DLMO.
3. Blocking melanopsin signaling pharmacologically (e.g., with intravitreal melanopsin antisense oligonucleotides in an animal model) will diminish both PLR amplitude and light‑induced phase shifts proportionally.

Methods Outline

• Sample: 60 healthy adults aged 18‑35, stratified by self‑reported chronotype (early, intermediate, late).
• Baseline: Dim‑light melatonin onset (DLMO

Hypothesis

Aging neurons accumulate somatic copy-number variations (CNVs) that alter the surface expression of complement proteins and phagocytic ligands. These CNV‑induced changes act as a genomic‑burden ‘eat‑me’ tag, marking metabolically inefficient or weakly connected neurons for removal by microglia. In individuals with clonal hematopoiesis of indeterminate potential (CHIP), mutated monocytes infiltrate the brain and differentiate into microglia that exhibit heightened complement receptor (CR3) signaling and oxidative burst capacity, thereby amplifying the clearance of CNV‑laden neurons. This process represents an active quality‑control mechanism that optimizes neural network efficiency under declining energy budgets, rather than passive neurodegeneration.

Mechanistic rationale

1. CNV burden alters neuronal surfaceome – Large‑scale CNVs (>1 Mb) frequently encompass genes encoding complement regulators (e.g., CD46, CD55) or ligands for microglial receptors (e.g., CX3CL1, MFGE8). Dosage shifts from these CNVs change the balance of ‘don’t‑eat‑me’ versus ‘eat‑me’ signals, tilting neurons toward phagocytic recognition【https://elifesciences.org/articles/39217】.
2. CHIP‑derived microglia are primed for phagocytosis – CHIP monocytes carrying mutations in DNMT3A, TET2, or ASXL1 adopt a microglial phenotype with up‑regulated ITGAM (CR3) and CYBB (NOX2) expression, enhancing their ability to recognize and engulf opsonized targets【https://pmc.ncbi.nlm.nih.gov/articles/PMC10353941/】.
3. Energy‑budget coupling – Neurons with high CNV load exhibit mit

Hypothesis

Mosaic chromosomal alterations (mCAs) are not merely passive markers of aging‑associated genomic instability; they actively shape the tissue microenvironment by altering the cargo of extracellular vesicles (EVs) released from affected cells. Specific mCAs—particularly copy‑neutral loss of heterozygosity (cnLOH) and large deletions—lead to aberrant DNA fragment generation that is packaged into EVs and transferred to neighboring stromal and immune cells. This EV‑mediated DNA transfer triggers innate immune sensing (cGAS‑STING) and a chronic senescence‑associated secretory phenotype (SASP), creating an inflammatory niche that favors the expansion of clones with growth‑advantage alterations (e.g., +12, ‑Y, del(13q)).

Rationale

• Large‑scale cohorts show that expanded autosomal mCAs (>10% fraction) increase hematologic cancer risk >100‑fold, with the highest HR for CLL (HR=121.9)【https://pmc.ncbi.nlm.nih.gov/articles/PMC7685330/】.
• mCAs elevate lung cancer risk, especially in smokers and cnLOH carriers (OR up to 1.56)【https://pmc.ncbi.nlm.nih.gov/articles/PMC10435278/】.
• Deletions predominate over duplications and correlate with genomic instability (Spearman rho=0.386)【https://pmc.ncbi.nlm.nih.gov/articles/PMC3014828/】.
• Tissue‑specific expansion patterns (pancreas ↑23‑fold recombinant cells, skin stable) indicate that clonal expansion dynamics, not mutation rate, drive age‑related mCA accumulation【https://pmc.ncbi.nlm.nih.gov/articles/PMC3014828/】.
• Unexpectedly, CNV prevalence is higher in centenarians than middle‑aged individuals, suggesting context‑dep

Age‑associated copy‑number variations (CNVs) accumulate in human colonic crypts, yet their functional impact on distal organs remains untested. We hypothesize that intestinal CNVs disrupt epithelial barrier integrity by altering dosage of tight‑junction and mucin genes, thereby increasing luminal bacterial translocation. This breach elevates systemic levels of microbial‑associated molecular patterns (MAMPs) such as LPS and peptidoglycan, which chronically activate innate immune cells in the lamina propria. Persistent MAMP exposure creates a selective pressure favoring the expansion of hematopoietic clones harboring mutations in epigenetic regulators (e.g., TET2, DNMT3A) that confer heightened inflammatory cytokine production—a process paralleling clonal hematopoiesis of indeterminate potential (CHIP). These myeloid‑derived clones release IL‑1β, IL‑6, and TNF‑α into the circulation, compromising blood‑brain barrier permeability and priming microglia and astrocytes toward a neurotoxic phenotype. Consequently, gut‑derived somatic instability initiates a cascade: epithelial CNV → barrier leak → MAMP‑driven immune clonal expansion → peripheral neuroinflammation → accelerated cognitive decline.

Key predictions that render this hypothesis falsifiable:

1. Individuals with high intestinal CNV burden (detected via deep sequencing of colon biopsies or stool‑derived epithelial DNA) will exhibit elevated serum LPS/LBP levels and a higher prevalence of CHIP mutations compared with age‑matched controls with low CNV load.
2. Longitudinally, the rate of CNV accumulation in intestinal epith

Hypothesis

Core idea: In cognitively normal aging, neuronal METTL3/14 expression declines, leading to loss of m6A on a subset of proteasome subunit transcripts. This reduces YTHDF1‑dependent translation, diminishes proteasome activity, and initiates a feed‑forward loop of proteostatic stress that further suppresses METTL3/14.

Mechanistic rationale

1. Writer loss: Aging neurons show reduced METTL3/14 protein (to be tested) despite stable mRNA, via increased proteasomal degradation of the writer complex triggered by low‑level oxidative stress Zhang et al., 2024.
2. Target selection: Bioinformatic analysis of aging brain m6A‑seq data reveals enrichment of m6A peaks in the 3'UTRs of proteasome genes (e.g., PSMB5, PSMC1, PSMD11) that are unchanged in total mRNA but show decreased ribosome occupancy et al., 2025.
3. Reader coupling: YTHDF1 binds these m6A sites and recruits eIF3 to enhance translation initiation; loss of m6A diminishes YTHDF1 occupancy, lowering protein synthesis without affecting mRNA stability (YTHDF2‑mediated decay unchanged) Liu et al., 2016.
4. Proteostatic collapse: Reduced proteasome subunit synthesis lowers 20S core assembly, decreasing chymotrypsin‑like activity, causing accumulation of ubiquitinated proteins that activate stress kinases (e.g., PKR) which phosphorylate and destabilize METTL3/14.
5. Vicious cycle: Proteostatic stress further inhibits METTL3/14, accele

Hypothesis: Persistent NF‑κB/NLRP3 inflammasome signaling in CD8⁺ T cells creates a self‑reinforcing circuit that locks the Cdkn2a (p16^INK4a) promoter into an open, transcriptionally active state via NLRP3‑dependent caspase‑1 cleavage of the histone deacetylase SIRT2. Early in life this circuit curtails excessive clonal expansion after infection, lowering the risk of autoimmunity and thus providing a selective advantage (antagonistic pleiotropy). After reproductive age, the same circuit drives irreversible senescence, exhausting T‑cell function and limiting tumor surveillance, which manifests as the observed increase in mortality and cancer incidence in older individuals.

Mechanistic

rationale: NLRP3 activation leads to caspase‑1–mediated SIRT2 cleavage, reducing SIRT2‑dependent deacetylation of H3K9 at the Cdkn2a locus. Loss of SIRT2 activity permits H3K9 acetylation, recruiting BRD4 and RNA polymerase II, thereby stabilizing p16^INK4a transcription independent of DNA damage signals. This epigenetic lock explains why transient antioxidant or NF‑κB inhibitors fail to reverse senescence when administered late in life, whereas early‑life blockade prevents the establishment of the open chromatin state.

Testable predictions: (1) In young mice, conditional NLRP3 deficiency in CD8⁺ T cells will increase the magnitude of primary viral responses without elevating autoantibody titers. (2) Aged mice with the same deficiency will show no reduction in p16^INK4a^+ T‑cell frequency or improvement in tumor clearance compared with controls, indicating irreversibility. (3) P

The age‑related drop in butyrate‑producing microbes is not merely a passive consequence of host frailty but an evolved mechanism that reduces cancer risk by curbing microbial metabolite load when immune surveillance weakens. We propose that declining butyrate lowers FFAR2/3 signaling in colonic epithelial cells, which in turn activates a transcriptional program that enhances xenobiotic detoxification and DNA repair while restraining proliferation. This shift protects against mutagenesis driven by residual bacterial activity as immunosenescence and inflammaging erode the host’s ability to control microbial overgrowth. If this hypothesis is correct, restoring butyrate levels in aged hosts should increase tumorigenesis despite improving barrier function and reducing systemic inflammation.

Testable predictions: (1) Aged mice receiving young‑donor fecal microbiota transplants or butyrate supplementation will show higher tumor burden in azoxymethane/dextran sulfate sodium‑induced colitis‑associated cancer models compared with aged controls receiving vehicle. (2) The increase in tumors will correlate with restored FFAR2/3 activation, reduced expression of detox enzymes (e.g., Nrf2 targets), and elevated epithelial proliferation markers (Ki‑67, PCNA). (3) Germ‑free aged mice colonized with a defined butyrate‑producing consortium will develop more tumors than those colonized with a butyrate‑deficient consortium, and this effect will be blocked by FFAR2/3 antagonism.

These experiments directly challenge the view that microbiome shifts in aging are purely passive dysbiosis. They

Hypothesis

Rapamycin’s inability to restore function after chronic inflammation stems not from inadequate mTORC1 suppression but from a fixed epigenetic‑metabolic lock in exhausted T‑cells. Once NF‑κB/NLRP3‑driven glycolysis stabilizes HIF‑1α and DNMT3a‑mediated methylation silences effector loci (e.g., Ifng, Tnf), mTOR inhibition alone cannot reactivate these genes because the transcriptional program is fixed downstream of mTOR. We propose that simultaneous inhibition of DNA methyltransferase 3a (DNMT3a) or HIF‑1α translation removes this lock, allowing rapamycin‑induced autophagy and metabolic remodeling to re‑establish a naïve‑like epigenetic landscape and restore effector function.

Mechanistic Reasoning

• Early rapamycin blocks mTORC1‑dependent HIF‑1α synthesis, limiting glycolytic flux and preserving mitochondrial oxidative phosphorylation, which keeps the Tbx21 and Gata3 loci accessible (see early mTOR inhibition prevents neuronal damage and inflammation)[https://onlinelibrary.wiley.com/doi/full/10.1111/jcmm.16702].
• In chronic settings, persistent NF‑κB/NLRP3 signaling activates HIF‑1α via ROS‑independent pathways and induces DNMT3a, leading to promoter methylation of cytokine genes and fixation of an exhausted transcriptome (mTORC1 hyperactivation downstream of NF‑κB/NLRP3 drives glycolysis and cytokine production in T‑cells)[https://pmc.ncbi.nlm.nih.gov/articles/PMC9280721/].
• Rapamycin still reduces mTORC1 activity but cannot demethylate DNA or destabilize HIF‑1α protein, so the cells remain metabolically skewed and transcriptionally silent.
• P

Hypothesis

Daily supplementation with 500 mg urolithin A (UA) will reduce the relative abundance of gut bacteria that convert dietary phenylalanine/tyrosine to phenylacetic acid (PAA), thereby lowering circulating PAA levels and synergistically enhancing UA‑driven mitophagy in CD8⁺ T cells.

Rationale

UA activates a calcium‑dependent mitophagy cascade that improves mitochondrial fitness and reverses aging signatures in immune cells [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12758194/]]. Conversely, age‑related microbiota shifts increase PAA, a metabolite that induces endothelial senescence via mitochondrial oxidative stress [[https://doi.org/10.1101/2023.11.17.567594]]. Although UA does not directly inhibit PAA synthesis, its ability to alter luminal redox state and promote mucin production could create an environment unfavorable for PAA‑generating taxa (e.g., certain Clostridia and Proteobacteria). Demonstrating that UA reshapes the microbiome to cut a pro‑aging metabolite would link two arms of the gut‑mitochondria axis and explain inter‑individual variability in UA responsiveness.

Predictions

1. After 24 weeks of UA supplementation, participants will show a ≥20 % decrease in the abundance of PAA‑producing bacteria relative to baseline, measured by 16S rRNA shotgun metagenomics.
2. Concurrently, plasma PAA concentrations will drop by ≥15 % compared with placebo.
3. The reduction in PAA will mediate additional improvements in mitophagy markers (phospho‑Parkin Ser65, ULK1) and immune phenotypes (increased youthful CD8⁺ T‑cell frequency, enhanced fatty‑acid oxidati